Close
Smartlab Europe
Achema middle east

News

New Zealand Health Groups Strive To Enhance Clinical Trials

Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies will examine system-level adjustments to enhance the benefits from clinical trials. The report was created by a broad team of...

Syneos Health Extends Partnership with Medable

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced it has extended its strategic partnership with Medable, the industry-leading technology platform for patient-centered clinical trials, as part of the Company’s commitment to bring clinical trials closer to the...

Hovione and GEA announce a strategic collaboration to advance Continuous Tableting

Hovione and GEA announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEA´s engineering expertise with Hovione´s development and manufacturing experience and both parties commit to partner...

Hyperparathyroidism: Symptoms, Causes and Treatment

Hyperparathyroidism is an extremely prevalent endocrine disorder. Recent studies reveal that about 80% of people in Western countries suffer from parathyroids. Additionally, about 1,00,000 people in the United States show symptoms yearly. A person suffering from the disease tends to...

Canadian And US Pharma Firms To Test Psychedelic Drugs In UK

To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a contract with the clinical research organisation (CRO) Clerkenwell Health to test treatments for mental health...

Swiss and French Health Authorities Expand Recommendations for Use of Nuvaxovid COVID-19 Vaccine as a Booster

Novavax announced that Switzerland’s Federal Office of Public Health (FOPH) and France’s Haute Autorité de Santé (HAS) have expanded their recommendations for use of Nuvaxovid™(NVX-CoV2373) as a COVID-19 booster. In Switzerland, the FOPH recommends use of Nuvaxovid as a booster...

Evaxion and ExpreS2ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate

Evaxion Biotech A/S , a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies,  announces that the Company has signed a Vaccine Discovery Collaboration Agreement with ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) for the joint...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »